This inventor holds 1 USPTO granted patent. Top assignee: Arexis Ab. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: The Innovations of Joel Gellin
Introduction
Joel Gellin is an accomplished inventor based in Auzeville, France. He has made significant contributions to the field of biotechnology, particularly in the area of energy metabolism. His work has implications for diagnosing and treating various metabolic dysfunctions.
Latest Patents
Gellin holds a patent for "Variants of the Gamma Chain of AMPX, DNA sequences encoding the same, and uses thereof." This patent focuses on the variants of the gamma chain of vertebrate AMP-activated kinase (AMPK), as well as nucleic acid sequences encoding these variants. The applications of this invention are crucial for the diagnosis or treatment of dysfunctions related to energy metabolism. He has 1 patent to his name.
Career Highlights
Throughout his career, Gellin has been dedicated to advancing scientific knowledge and practical applications in biotechnology. His innovative approach has led to breakthroughs that enhance our understanding of metabolic processes.
Collaborations
Gellin has worked alongside notable colleagues, including Ernst Kalm and Nathalie Iannuccelli. Their collaborative efforts have contributed to the success of various projects and research initiatives.
Conclusion
Joel Gellin's work exemplifies the impact of innovation in biotechnology. His contributions continue to pave the way for advancements in the diagnosis and treatment of metabolic disorders.